The EACPT is delighted to announce that the 2013 EACPT Scientific Award goes to Dr David Devos from the Department of Medical Pharmacology at the Université Lille Nord de France. The EACPT Scientific Award is for the report by Dr Devos about a new approach to treating Parkinson’s disease.
The paper, for which Dr Devos was corresponding author, was published in the July 2012 issue of
|Dr David Devos|
the high impact international journal – Lancet Neurology, entitled:
‘Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.’
The prize, which includes a 2000 € award, will be presented to Dr Devos at the 11th EACPT Congress in Geneva 28th – 31st August 2013.
David Devos obtained his Doctor of Neurology and Doctor of Neuroscience degrees from the University of Lille, France. Between 2002 and 2010, he worked as a hospital physician in the Department of Neurology of the Centre Hospitalier Universitaire of Lille, where he is now associate professor in medical pharmacology (Lille Nord de France University, EA1046/EA4559). His main research interest is in developing new symptomatic and disease-modifying strategies in neurodegenerative diseases, such as Parkinson’s disease, amyotrophic lateral sclerosis, dementia and cerebellar ataxia. His researches are mainly based upon clinical trials but also include preclinical, translational and clinical studies in neuropsychopharmacology.
The EACPT Scientific Award is for the best scientific paper on a topic relevant to clinical pharmacology and therapeutics published by a European clinical pharmacologist over the period between EACPT congresses, based on nominations by the EACPT Council. The award has a value of 2000 €. Criteria are scientific quality, broader impact in science, and the importance of the work in the context of healthcare delivery.
The EACPT was founded 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.
Official EACPT journal: Clinical Therapeutics
More about the 11th EACPT Congress in Geneva.
More about the EACPT.